USANA Health Sciences

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

USANA Health Sciences addresses challenges, eyes growth through cost management

USANA Health Sciences navigated a challenging operating environment by focusing on cost management, product demand trends, and growth strategies. Despite facing headwinds in China and Southeast Asia, the company remains resilient and poised for opportunities in new markets and acquisitions.

USANA Health Sciences reports solid Q1 results amid global challenges

USANA Health Sciences delivered strong Q1 results amidst global challenges, driven by robust demand for health products.
Strategic leadership transition and focus on cost management position the company for sustained growth and operational efficiency.
Opportunities in China market, new market launches, and enhanced customer engagement strategies offer avenues for future expansion.

USANA Health Sciences exceeds Q2 expectations, eyes India expansion

USANA Health Sciences delivered strong Q2 results with a focus on sustainable growth strategies and expansion into new markets. Challenges include tough year-over-year comparisons and cash flow impact from accrued liabilities.

USANA Health Sciences addresses challenges, eyes India expansion for growth

USANA Health Sciences navigated challenges in Q3 2023 with a focus on addressing operational hurdles and driving growth through strategic initiatives. The company's restructuring and expansion into India signal a commitment to long-term success and capitalizing on emerging opportunities.

USANA Health Sciences exceeds Q4 expectations, eyes global growth

USANA Health Sciences delivered strong performance in Q4 2023, driven by growth in Greater China and a solid financial position. While facing challenges such as currency fluctuations and market-specific issues, the company is well-positioned to capitalize on opportunities through strategic initiatives and market tailoring. By focusing on sustainable growth and innovation, USANA aims to further strengthen its market presence and drive profitability.

USANA Health Sciences reports mixed Q1 results, eyes growth strategies

USANA Health Sciences faced mixed results in Q1 2024, with Mainland China driving growth while other markets struggled. The company is addressing challenges through market-specific incentives and focusing on future strategies like product development and localization.

USANA Health Sciences adapts to market challenges with strategic focus

USANA Health Sciences navigated macroeconomic challenges by implementing strategic initiatives and restructuring its commercial team.
The company's focus on product innovation, market expansion into India, and leadership additions signal a commitment to sustainable success.
While facing challenges in market conditions, USANA aims to leverage opportunities like M&A activities and accelerated product development for growth.

USANA Health Sciences adapts strategies to drive growth amid challenges

USANA Health Sciences faced challenges in Q3 with lower-than-expected net sales, particularly in China, but is implementing strategies to boost performance.
The company's strengths in product innovation, streamlined development processes, and strong product lineup position it well for future growth.
Addressing challenges such as decreased average spend and revised guidance presents opportunities for USANA to enhance revenue and market presence.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rachel Brewer named to Utah Business ' 30 Women to Watch SALT LAKE CITY ,  May 24, 2023 /PRNewswire/ -- USANA is proud to announce Executive Director of Research and Development Rachel Brewer, Ph.D., as one of Utah Business magazine's 30 Women to Watch.

USANA Executive Director honored at Utah event

Highlighting USANA's ongoing commitment to people, planet, and products SALT LAKE CITY , May 22, 2023 /PRNewswire/ -- As a global leader in health and wellness, USANA strives to do its part in caring for the planet and its inhabitants. And with a focus on positive business practices, USANA recently released its third annual sustainability report.

USANA Releases 2022 Sustainability Report

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced its plans to expand into India in the second half of 2023. Expansion into India increases the Company's global footprint to 25 markets. “USANA's expansion into India is our first new market in five years and provides an exciting and gratifying opportunity to introduce USANA's world class health and wellness products to a new country, culture and demographic,” said Jim Brown, President. “We have spent sever.

USANA Health Sciences Announces Plans to Expand into India

SALT LAKE CITY , May 2, 2023 /PRNewswire/ -- Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA), shares five steps to stay on track during May's National Recommitment Month. In his bestselling book, All the Right Reasons, 12 Timeless Principles for Living a Life in Harmony, Guest emphasizes the importance of achieving goals in harmony with one's core values.

Kevin Guest Shares 5 Secrets for National Recommitment Month of May

USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About USANA Health (USNA) Rating Upgrade to Buy

USANA Health Sciences, Inc. (USNA) Q1 2023 Earnings Call Transcript.

USANA Health Sciences, Inc. (USNA) Q1 2023 Earnings Call Transcript

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended April 1, 2023. Key Financial & Operating Results First quarter net sales were $248 million versus $228 million for the fourth quarter of 2022 and $273 million during the first quarter of 2022. First quarter diluted EPS was $0.95 as compared with $0.66 for the fourth quarter of 2022 and $1.15 during the first quarter of 2022. Generated $13 million of.

USANA Health Sciences Reports First Quarter Net Sales of $248 Million and Diluted EPS of $0.95

USANA Korea Receives two honors at the 2023 Korea Medical Healthcare Awards SEOUL, South Korea , April 20, 2023 /PRNewswire/ -- USANA Health Sciences, a global cellular nutrition company, won two awards from Korea Medical Healthcare Awards. The first for its HealthPak in the multivitamin category and the second for Nutrimeal Active in the food weight-management category.

USANA Korea Delivers as a Global Cellular Nutrition Company

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter results will be released after the close of market on Tuesday, April 25, 2023. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section.

USANA Schedules First Quarter Earnings Release and Conference Call

SALT LAKE CITY , April 3, 2023 /PRNewswire/ -- Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA), urges people to celebrate April's International Guitar Month by finding harmony in life through music. A musician himself, Guest owns 15 guitars and has found music to be medicine for the soul.

Kevin Guest Encourages Finding Harmony in Life Through Music For April's International Guitar Month

Euromonitor International honors USANA Hong Kong HONG KONG , March 29, 2023 /PRNewswire/ -- USANA Hong Kong was recently recognized as a top brand for calcium supplements by market research giant Euromonitor International. This distinction is based on market research of USANA's MagneCal D supplement and its retail value sales data compared to other brands in the industry.

USANA Ranked #1 Direct Selling Brand for Calcium Supplements in Hong Kong

Named among 100 Utah companies championing women SALT LAKE CITY , March 23, 2023 /PRNewswire/ -- Creating an environment of equity and inclusion for women in the workplace is an important focus for USANA, which was recently recognized for its efforts in this area. Utah Governor Spencer J.

Utah Governor's Office Recognizes USANA for Its Support of Women in the Workplace

Herbalife

Nu Skin Enterprises

Tupperware

This isn't your grandmother's environment for growing an MLM company. How long can Net Margins be sustained with declining Gross Margins and Operating Margins?

Multilevel Marketing: 2018 And Beyond?

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, is scheduled to participate in upcoming investor conferences. Details for each event are as follows: 35th Annual Roth Conference Monday, March 13, 2023 1x1 Investor Meetings Dana Point, CA D.A.

USANA Health Sciences to Participate in Upcoming Investor Conferences

Bestselling Author Shares Ways to Make Work Fun, Fulfilling SALT LAKE CITY , March 1, 2023 /PRNewswire/ -- With March 2023 designated as Employee Spirit Month, which honors all hard-working employees, a bestselling author is sharing five ways to boost employee morale for ongoing, upward progress. "When employee morale is high, we see productivity soar, so it's important to keep morale at a high level for many reasons," said Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA), a billion-dollar nutritional supplement company in 24 worldwide markets.

Kevin Guest Honors Workers in March Employee Spirit Month

Jessica Arias named to Utah Business magazine's 40 Under 40 SALT LAKE CITY , Feb. 23, 2023 /PRNewswire/ -- USANA Health Sciences, Inc. congratulates Jessica Arias, executive director of marketing, social media, and portfolio, for being named a 40 Under 40 award winner by Utah Business magazine. To find out more about USANA and its products, please visit USANA.com.

USANA Executive Director Takes Home Utah Award

Usana Health Services, maker of nutritional supplements, on Monday announced that Chief Executive Kevin Guest will become executive chairman effective July 1 in accordance with the company's succession strategy. Guest has been CEO since 2015 and chairman of the board since 2020.

Usana names new CEO

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced that consistent with the Company's planned succession strategy, Kevin Guest, USANA's Chief Executive Officer (CEO) since 2015 and Chairman of the Board since 2020, will transition to the role of Executive Chairman of the Company, effective July 1, 2023. At that time, Jim Brown, USANA's current President, will be named CEO of the Company.

USANA Health Sciences Announces CEO Transition Plan

USANA Health Sciences, Inc. (NYSE:USNA ) Q4 2022 Earnings Conference Call February 8, 2023 11:00 AM ET Company Participants Andrew Masuda - Investor Relations Kevin Guest - Chairman and Chief Executive Officer Jim Brown - President Doug Hekking - Chief Financial Officer Brent Neidig - Chief Officer and Managing Director, China Conference Call Participants Linda Bolton-Weiser - D.A. Davidson Susan Anderson - Canaccord Genuity Ivan Feinseth - Tigress Financial Partners Operator Good day and welcome to today's USANA Health Sciences Fourth Quarter Earnings Conference Call.

USANA Health Sciences, Inc. (USNA) Q4 2022 Earnings Call Transcript

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and full year ended December 31, 2022. Key Financial & Operating Results Fourth quarter net sales were $228 million versus $267 million during the prior-year period. Fourth quarter diluted EPS was $0.66 as compared with $1.03 during Q4 2021. Fiscal year 2022 net sales were $999 million as compared with $1,186 million during fiscal year 2021.

USANA Health Sciences Reports Fourth Quarter and Fiscal Year 2022 Results

Bestselling Author Kevin Guest Shares 7 Ways Music Positively Influences SALT LAKE CITY , Feb. 1, 2023 /PRNewswire/ -- As February 3 marks "The Day the Music Died," a day to celebrate the power of music and the icons that have influenced us, a bestselling author is sharing ways music can positively influence people across the world. "Music is medicine for the soul, and this is the perfect time to celebrate music icons and the influence music has on us," said Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA), and author of All the Right Reasons, 12 Timeless Principles for Living a Life in Harmony.

The Day the Music Died Celebrates Music, Brings Harmony

Share Your Favorite USANA Products—and Earn SALT LAKE CITY , Jan. 17, 2023 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in nutrition, recently launched its Affiliate Program—a new and exciting way to share USANA products and earn. This unique opportunity appeals to an even broader range of USANA customers and entrepreneurs.

Health and Wellness Company Launches New Affiliate Program

Usana Health Sciences Inc. shares fell more than 4% in the extended session Thursday after the multi-level marketing company called for lower 2023 sales and profit than Wall Street expected, saying it is unsure whether an uptick in sales at the end of 2022 would last.

Usana sees sales bump in China, but 2023 still uncertain

SALT LAKE CITY--( BUSINESS WIRE )--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary fiscal year 2022 results and initial guidance for fiscal year 2023 ahead of its presentation at the 25th Annual ICR Conference.

USANA Health Sciences Provides Preliminary Fiscal Year 2022 Results and Issues Initial Fiscal Year 2023 Outlook

SALT LAKE CITY , Jan. 3, 2023 /PRNewswire/ -- To kickstart 2023, bestselling author Kevin Guest is encouraging others to start something during January's National Rising Star Month. Drawing from his bestselling book, All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony, Guest shares lessons of how taking risks and starting a worthy habit can elevate a person to success in personal and professional efforts.

News for USANA Health Sciences Stock (USNA)